In Vitro Maturation of Immature Oocytes
Sponsor
Sheba Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT00480337
Collaborator
(none)
1
Study Details
Study Description
Brief Summary
The aim of this study is to aspirate immature oocytes from antral follicles and mature the oocytes in vitro. These mature oocytes will serve for fertilization and the creation of embryos which will be replace in the uterus as performed during normal IVF.We will record the efficacy and safety of this procedure.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
20 Years
to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
-
Women with PCOS
-
Women with previous Hyperstimulation or with risk of developing hyperstimulation during IVF Treatment
-
Women diagnosed with cancer who are interested in fertility preservation
-
Women with repeated IVF failure
Exclusion Criteria:
-
Severe cases of endometriosis
-
Large myomas
-
Hydrosalpinxs Technical problem with previous oocytes pick-up
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | IVF Unit, Shea Medical Center, Tel-Hashomer | Ramat-Gan | Israel | 52621 |
Sponsors and Collaborators
- Sheba Medical Center
Investigators
- Principal Investigator: Ariel Hourvitz, IVF Unit, Sheba Medical Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00480337
Other Study ID Numbers:
- SHEBA-06-4317-AH-CTIL
First Posted:
May 30, 2007
Last Update Posted:
Dec 17, 2008
Last Verified:
Dec 1, 2008
Keywords provided by ,
,
Additional relevant MeSH terms: